AIM ImmunoTech (AIM) Provides Update on Ampligen Long COVID Development Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Aerosonic Corp. (NYSE: AIM) | Delayed: 0.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.16 | 52 Week High | $8.92 | |||
| Open | $0.16 | 52 Week Low | $2.64 | |||
| Day High | $0.17 | P/E | 0.26 | |||
| Day Low | $0.16 | EPS | $0.62 | |||
| Volume | 325,708 | |||||
